Bank of New York Mellon’s Opexa Therapeutics, Inc. OPXAW Stock Holding History

Bank of New York Mellon's OPXAW Position: Q3 2017 in Review

Bank of New York Mellon sold out of Opexa Therapeutics, Inc. (OPXAW) in Q3 2017, closing a stake of 50,000 shares — an estimated $6K sold.

Bank of New York Mellon first reported a position in OPXAW in Q1 2017 and held it in 2 quarters. The position peaked at $6K in Q2 2017. 0 funds tracked by Wall St. Rank hold OPXAW as of Q3 2017.

• Bank of New York Mellon reported no remaining Opexa Therapeutics, Inc. position as of Q3 2017 after selling out during the quarter.
• Bank of New York Mellon sold 50,000 Opexa Therapeutics, Inc. shares in Q3 2017, an estimated $6K.
• Bank of New York Mellon first reported a position in Opexa Therapeutics, Inc. in Q1 2017 and held it in 2 quarters.
• Bank of New York Mellon's Opexa Therapeutics, Inc. position peaked at $6K in Q2 2017.
• 0 funds tracked by Wall St. Rank held Opexa Therapeutics, Inc. as of Q3 2017.

Based on Bank of New York Mellon's 13F filing for Q3 2017, filed 6 Nov 2017.